Trial dose range: 112mg, once weekly, subcutaneous Standard escalation: 2mg +2mg every 4 weeks 12mg (~20 weeks) Pharmacokinetics: half-life ~6 days
The reduced caloric intake, combined with metabolic adaptation, can produce feelings of low energy during the first several weeks at each new dose level
Prospective patients will need to factor in membership fee + medication cost, and determine if it fits within their budget
Our prior authorization support ensures seamless communication until approval, allowing you to focus solely on your treatment journey
By progressing from a lower dose to a higher one, patients can achieve optimal glycemic control while minimizing the risk of adverse reactions
Particularly beneficial for patients with insulin resistance or PCOS in weight management programs